Introduction
Provide comprehensive protection for your children. It is effective against 86.4% of invasive pneumococcal disease cases in children (contains 20 purified capsular polysaccharides of S. pneumoniae: 1, 3, 4, 5, 6A, 7F, 8, 9V, 10A, 11A , 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F and 33F)
+51% and +63% protection than the existing 15-valent and 13-valent pneumonia vaccines respectively.
It is verified by many countries (including Australia, Japan, and the United Kingdom), and it effectively reduces cases of otitis media and invasive pneumococcal disease.
Vaccination is available for individuals aged 6 weeks and above
First dose: 2 months; Second dose: 4 months; Third dose: 6 months; Forth dose: 12-15 months (4 injections in total)
Individuals aged 2 years and above (including adults and seniors): only one dose is needed.
Manufacturer
PFIZER
Prevention
Pneumococcus (Streptococcus pneumoniae, or S. pneumoniae)